This study reveals that COL1A2 drives the transition from non-muscle-invasive to muscle-invasive bladder cancer via a spatially resolved ECM-FAK signaling axis, delineated through single-cell transcriptomics. The gene discussed is PTK2; the disease is urinary bladder cancer.